» Authors » A J Vickers

A J Vickers

Explore the profile of A J Vickers including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 29
Citations 1266
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Matulewicz R, Baky F, Liso N, Williams B, Porwal S, Assel M, et al.
Ann Oncol . 2025 Mar; PMID: 40073938
Background: Post-chemotherapy retroperitoneal lymph node dissection (pcRPLND) is integral to multimodal treatment of patients with metastatic non-seminomatous germ cell tumors (NSGCT). We review pathologic and long-term outcomes of pcRPLND following...
2.
Mee T, Vickers A, Jena R, Kirkby K, Choudhury A, Kirkby N
Clin Oncol (R Coll Radiol) . 2021 Mar; 33(7):e285-e294. PMID: 33775495
Aims: Cancer incidence varies across England, which affects the local-level demand for treatments. The magnetic resonance-linac (MR-linac) is a new radiotherapy technology that combines imaging and treatment. Here we model...
3.
Stonier T, Tin A, Sjoberg D, Jibara G, Vickers A, Fine S, et al.
J Urol . 2020 Nov; 205(4):1063-1068. PMID: 33216696
Purpose: The National Comprehensive Cancer Network® recommends that selected men with grade group 2 prostate cancer be considered for active surveillance. However, selecting which patients with grade group 2 disease...
4.
MacPherson H, Vertosick E, Foster N, Lewith G, Linde K, Sherman K, et al.
Pain . 2016 Oct; 158(5):784-793. PMID: 27764035
There is uncertainty regarding how long the effects of acupuncture treatment persist after a course of treatment. We aimed to determine the trajectory of pain scores over time after acupuncture,...
5.
Poyet C, Wettstein M, Lundon D, Bhindi B, Kulkarni G, Saba K, et al.
J Urol . 2016 May; 196(5):1402-1407. PMID: 27188476
Purpose: We externally validated a novel prostate cancer risk calculator based on data from the Swiss arm of the ERSPC and assessed whether the risk calculator (ProstateCheck) is superior to...
6.
Xylinas E, Kent M, Kluth L, Pycha A, Comploj E, Svatek R, et al.
Br J Cancer . 2013 Aug; 109(6):1460-6. PMID: 23982601
Background: The European Organization for Research and Treatment of Cancer (EORTC) risk tables and the Spanish Urological Club for Oncological Treatment (CUETO) scoring model are the two best-established predictive tools...
7.
Gupta A, Roobol M, Savage C, Peltola M, Pettersson K, Scardino P, et al.
Br J Cancer . 2010 Jul; 103(5):708-14. PMID: 20664589
Background: Most men with elevated levels of prostate-specific antigen (PSA) do not have prostate cancer, leading to a large number of unnecessary biopsies. A statistical model based on a panel...
8.
Vickers A, Smith C
Cochrane Database Syst Rev . 2006 Jul; (3):CD001957. PMID: 16855981
Background: Influenza is a highly infectious viral disease that is particularly common in the winter months. Oscillococcinum is a patented, commercially available homoeopathic medicine. The rationale for its use in...
9.
Vickers A, Rees R, Zollman C, McCarney R, Smith C, Ellis N, et al.
Health Technol Assess . 2004 Nov; 8(48):iii, 1-35. PMID: 15527670
Objectives: To determine the effects of a policy of using acupuncture, compared with a policy of avoiding acupuncture, on headache in primary care patients with chronic headache disorders. The effects...
10.
Vickers A, Smith C
Cochrane Database Syst Rev . 2004 Feb; (1):CD001957. PMID: 14973976
Background: Influenza is a highly infectious viral disease that is particularly common in the winter months. Oscillococcinum is a patented, commercially available homoeopathic medicine. The rationale for its use in...